Navigation Links
Ten Years of Advancing Excellence in African Healthcare: Pfizer and Accordia Join Forces to Improve Health Services for Underserved Populations
Date:1/10/2014

(PRWEB) January 10, 2014

Accordia Global Health Foundation and Pfizer Inc. have collaborated for the past decade to advance the activities and impact of the Infectious Diseases Institute (IDI), Accordia’s flagship center of excellence in Uganda. Among their most effective alliances is the Pfizer Global Health Fellows program (GHF). Pfizer’s signature corporate social investment and volunteer program, GHF places employees with international development organizations to improve health services for underserved people in developing countries. During assignments, Fellows transfer their professional medical and business expertise in ways that promote access, quality, and efficiency of health services for people in greatest need. At the same time, Fellows gain insights into health challenges in emerging markets and build leadership skills.

Of the more than 300 Pfizer employees who have participated in the GHF program since 2003, 18 have been assigned to Accordia and placed at IDI, which has an estimated value of approximately $2.7 million in pro bono service. The nonprofit IDI, located at Makerere University in Kampala, works to build the capacity of health systems in Africa for the delivery of high-quality care, treatment, and prevention services—with a strong emphasis on infectious diseases—through training, research, and the development of new models of care.

Generating immediate results and long-lasting operational changes, the Fellows have advanced IDI’s management and clinical systems, research capacity, and communications. They have worked with IDI staff to improve teaching curricula, quality assurance processes, information technology, facility maintenance, advocacy, and proposal writing. The Fellows worked to empower patients by creating a resource center and an advocacy council and by organizing community mobilization and sensitization.

The Power of Collaboration
In an effort to ensure that these improvements continue after they return to their jobs at Pfizer, the Fellows are often paired with IDI staff members to help them build skills and confidence. Andreas Kuznik, PhD worked with a team of IDI researchers interested in health economics, collaboratively writing four papers that have been accepted for publication in peer-reviewed journals. These include important findings on the cost effectiveness of reducing HIV transmission from mothers to babies and on syphilis screening in the antenatal care setting. Kuznik worked closely with Mohammed Lamorde, PhD, who now heads both the Clinical Trials and Health Economics/Cost-effectiveness units at IDI.

Fellow Inka Schuermann made improvements to IDI’s Prevention, Care, and Treatment operations, implementing a quality assurance program and strengthening the capacity of research teams to conduct clinical trials. Schuermann worked alongside IDI’s Rachel Musomba Zimaze, who went on to become the Institute’s quality manager. "I believe Inka’s commitment to helping us to develop quality assurance will be the foundation for continued emphasis on quality care in the years ahead," said Dr. Rosalind Parkes-Ratanshi, head of the clinic. "What she managed to do in five months was really incredible, and she leaves us with a strong system and a well-trained quality manager to continue the implementation."

Pfizer scientist and business development expert Janet White built on the Institute’s strategic planning and clinical trial management. She helped create a five-year plan to financially support the organization’s research program, tapping new sources of funding. She also collaborated with Allen Mukhwana, Research Senior Programme Administrator, for more than three months to augment IDI’s research office and its ability to manage clinical trials. A comprehensive case study recaps the Fellows’ work at IDI.

Moving Forward
Pfizer and Accordia announce the new placement of an employee from Pfizer’s Nigerian office to serve on a five-month fellowship at the West African Infectious Diseases Institute in 2014. Based in Abuja, Nigeria, the institute is a collaborative multi-university organization with a mission to support and improve locally driven research and training across all infectious diseases. Kodjo Soroh, M.D., is a Medical Director, based in Lagos, Nigeria, for the Northeast African region. He will focus on outreach to and engagement of the faculty at WAIDI’s member universities, 12 of the leading academic institutions in Nigeria. In addition, Dr. Soroh will work on developing bilateral agreements with these founding institutional members to support multi-institutional research collaboration, and promote the use of this research in setting strong health policy and ensuring effective practice and scale. This fellowship is a first for WAIDI and Accordia’s initial placement in Nigeria.

About Accordia

Accordia Global Health Foundation is a Washington, DC-based nonprofit organization dedicated to solving Africa’s pressing health needs by building and supporting sustainable African health institutions. Armed with a vision of creating a continent-wide network of centers of excellence in health, Accordia is helping to prepare a new generation of African health leaders to manage world-class research, training, and service delivery. Accordia, in conjunction with its cadre of distinguished experts from the world’s leading academic institutions, provides guidance and develops management processes and systems that help these centers succeed. Accordia works in partnership with individuals, corporations, foundations, and governments to bring private-sector efficiency and academic innovation to its technical assistance activities.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11474700.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Breast Cancer Treatment Side Effects May Last for Years
3. Life expectancy and healthy life years in the European Union, 2008-2010
4. Measles Outbreaks in 2011 Were Worst in 15 Years: CDC
5. 16 years old is peak risk for teens misusing prescription drugs
6. NAMS journal Menopause reflects on the WHI 10 years later
7. After 25 years, World No Tobacco Day is making an impact
8. Elreg Distributors Ltd. Celebrates 32 Years in Business
9. Weight-Loss Surgery Cuts Heart Risk 7 Years Later: Study
10. For Combat Vets, Brain Injury Symptoms Can Last Years
11. New Electronic Cigarette Free Trial Kit Adds More Years to Smokers Life by Making it Easy to Quit Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology: